Goldman Sachs Upgrades Varian Medical (VAR) to Neutral on Stabilization
Tweet Send to a Friend
Goldman Sachs upgraded Varian Medical (NYSE: VAR) from Sell to Neutral with a price target of $79.00 (from $62.00).
This article: 112 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This article: 112 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
